Kenyon C. Dual azithromycin/ceftriaxone therapy for gonorrhoea in PrEP cohorts results in levels of macrolide consumption that exceed resistance thresholds by up to 7-fold. J Infect Dis 2021 Apr 2. pii: 6209316. doi: 10.1093.
PMID: 33822092